IBAB — Ion Beam Applications SA Share News
0.000.00%
- €491.66m
- €566.81m
- €620.18m
Brief: IBA: Japanese Approval For Reimbursement Of Amyloid-PET Diagnostic Neuraceq In Alzheimer's Disease
Brief: IBA Confirms Mid-Term Guidance
Brief: IBA Signs Total System Restoration Contract With Massachusetts General Hospital
Brief: IBA Announces It Has Signed Final Contract With Medtechnica
IBA drops to 34-month lows as H1 REBIT turns negative
Brief: Ion Beam Applications H1 Net Income at EUR -27.3 Million
Brief: IBA Confirms FY Outlook
Brief: IBA: Terrapower Isotopes And Pantera Announce Strategic Collaboration
Brief: IBA, PARTICLE Initiate FLASH Proton Therapy Research Partnership
Brief: IBA Signs Contract For Installation Of Proteus Plus System In China
Brief: IBA Signs Binding Term Sheet With Medtechnica For Two Proteus One Proton Therapy Solutions
Brief: IBA Q1 Net Cash Position At EUR 103 Million
IBA annonce ses résultats annuels pour 2022
IBA Reports Full Year 2022 Results
Brief: IBA FY Total Group Net Profit Up At EUR 6.1 Million
Brief: IBA Plans To Hire 100 New Employees By June 2023
Brief: IBA Gets Downpayment For Contract With Moffitt
Brief: IBA Signs Fully Integrated X-Ray Irradiation Solution Contract In France
IBA jumps on Spanish proton therapy system deal